Search - tctmd.com

Displaying 801 - 820 of 1023

Sort: Relevancy | Date

Presentation TCT 2014

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Presenter: Jacek Bil

September 16, 2014

Presentation TCT 2014

Dedicated Bifurcation BiOSS® Stent In The Treatment Of Distal Left Main Stem Stenosis ? International Registry_

Presenter: Jacek Bil

September 16, 2014

Presentation TCT 2014

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Presenter: Keith Oldroyd

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Arif Al Nooryani

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Yoshinobu Onuma

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Jens Flensted Lassen

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, John A. Ormiston

September 15, 2014

Presentation TCT 2014

Is There a Role for a Dedicated Bifurcation Stent Device? Landscape and Lessons from the Tryton Trial

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Antonio L. Bartorelli

September 15, 2014

Presentation TCT 2014

Potential Role for a Self-Expanding Stent in Bifurcations: Final OPEN II Results

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Christoph K. Naber

September 15, 2014

Presentation TCT 2014

Do Drug-Eluting Balloons Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Kenneth Chin

September 15, 2014

Presentation TCT 2014

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ran Kornowski

September 15, 2014

Presentation TCT 2014

Choice of Metallic DES Stents for Bifurcation Stenting

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Francesco Burzotta

September 15, 2014

Presentation TCT 2014

Does IVUS Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, Ioannis Iakovou

September 15, 2014

Presentation TCT 2014

Does FFR Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Presenter: Bernard R. Chevalier, Leif Thuesen, Ricardo A. Costa, William F. Fearon

September 15, 2014

Presentation TCT 2014

Insights from the COBIS Registries

Presenter: Jens Flensted Lassen, Thierry Lefevre, Issam D. Moussa, Hyeon-Cheol Gwon

September 15, 2014

Presentation TCT 2014

Insights from the DK Crush Trials

Presenter: Jens Flensted Lassen, Thierry Lefevre, Issam D. Moussa, Shao Liang Chen

September 15, 2014

Presentation TCT 2014

Lessons from the BBC Trials: Summary of Trials and Data Gaps

Presenter: Jens Flensted Lassen, Thierry Lefevre, Issam D. Moussa, David Hildick-Smith

September 15, 2014

Presentation TCT 2014

Lessons from the Nordic Trials: Summary of Trials and Data Gaps

Presenter: Jens Flensted Lassen, Thierry Lefevre, Issam D. Moussa, Leif Thuesen

September 15, 2014

Presentation TCT 2014

Bifurcation Lesion Preparation: Critical Appraisal and Recommendations

Presenter: Yves R. Louvard, Bernhard Reimers, Elvin Kedhi, D. Christopher Metzger

September 15, 2014

Presentation TCT 2014

Nuances of Kissing Balloon Inflation: From POT to Timing

Presenter: Yves R. Louvard, Bernhard Reimers, Elvin Kedhi, Dong-Ho Shin

September 15, 2014

Advertisement

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Dedicated Bifurcation BiOSS® Stent In The Treatment Of Distal Left Main Stem Stenosis ? International Registry_

2-year outcomes and angiograms from the bifurcation subgroup of the e-BioMatrix registry

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Bioresorbable Scaffold Use in Bifurcation Requires Different Technique

Is There a Role for a Dedicated Bifurcation Stent Device? Landscape and Lessons from the Tryton Trial

Potential Role for a Self-Expanding Stent in Bifurcations: Final OPEN II Results

Do Drug-Eluting Balloons Have Anything to Offer for Bifurcation Treatment? From Theory to Data

TCT 181: A Comparative Prospective Analysis of a Drug-Eluting Stent with Biodegradable Polymer Versus a Drug-Eluting Stent with Permanent Polymer in Bifurcation Lesions

Choice of Metallic DES Stents for Bifurcation Stenting

Does IVUS Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Does FFR Have Anything to Offer for Bifurcation Treatment? From Theory to Data

Insights from the COBIS Registries

Insights from the DK Crush Trials

Lessons from the BBC Trials: Summary of Trials and Data Gaps

Lessons from the Nordic Trials: Summary of Trials and Data Gaps

Bifurcation Lesion Preparation: Critical Appraisal and Recommendations

Nuances of Kissing Balloon Inflation: From POT to Timing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content